ASX - By Stock
|
1AD |
Re:
Ann: Investor presentation
|
|
DjohnR
|
9 |
2.0K |
2 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
9
|
2.0K
|
2
|
|
ASX - By Stock
|
TYP |
Re:
When can we buy?
|
|
DjohnR
|
10 |
3.7K |
0 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
10
|
3.7K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
When can we buy?
|
|
DjohnR
|
10 |
3.7K |
0 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
10
|
3.7K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
DjohnR
|
118 |
43K |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
118
|
43K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
DjohnR
|
118 |
24K |
7 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
118
|
24K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Notification of Quarterly Results & Investor, Revised
|
|
DjohnR
|
58 |
18K |
3 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
58
|
18K
|
3
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Investor webinar presentation
|
|
DjohnR
|
32 |
6.6K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
32
|
6.6K
|
1
|
|
ASX - By Stock
|
RLF |
Re:
Ann: Trading Halt
|
|
DjohnR
|
3 |
1.0K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
3
|
1.0K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Down 100%??
|
|
DjohnR
|
5 |
2.2K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
5
|
2.2K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Down 100%??
|
|
DjohnR
|
5 |
2.2K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
5
|
2.2K
|
0
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Notification of Expiry of Listed Options
|
|
DjohnR
|
6 |
1.1K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
6
|
1.1K
|
1
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Althea Announces Distribution Agreement With Symbion
|
|
DjohnR
|
5 |
1.9K |
6 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
5
|
1.9K
|
6
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
DjohnR
|
126 |
27K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
126
|
27K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
DjohnR
|
126 |
27K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
126
|
27K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
DjohnR
|
126 |
27K |
3 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
126
|
27K
|
3
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
DjohnR
|
126 |
27K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
27K
|
1
|
|
ASX - By Stock
|
RLF |
Re:
Crack the Code!
|
|
DjohnR
|
13 |
3.9K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
13
|
3.9K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
DjohnR
|
126 |
27K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
27K
|
3
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
DjohnR
|
126 |
27K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
126
|
27K
|
4
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNBV MoU Webinar presentation
|
|
DjohnR
|
90 |
18K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
90
|
18K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Final Director's Interest Notice MB
|
|
DjohnR
|
16 |
5.9K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
16
|
5.9K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNBV MoU Webinar presentation
|
|
DjohnR
|
90 |
18K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
90
|
18K
|
0
|
|
ASX - By Stock
|
IPD |
Re:
Q2 predictions?
|
|
DjohnR
|
55 |
18K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
55
|
18K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Positive AD-214 Phase I extension study results
|
|
DjohnR
|
262 |
54K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
262
|
54K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Final Director's Interest Notice MB
|
|
DjohnR
|
16 |
5.9K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
16
|
5.9K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Positive AD-214 Phase I extension study results
|
|
DjohnR
|
262 |
54K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
262
|
54K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
DjohnR
|
488 |
221K |
1 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
488
|
221K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Media
|
|
DjohnR
|
210 |
72K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
210
|
72K
|
4
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Corporate Presentation
|
|
DjohnR
|
118 |
25K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
118
|
25K
|
6
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Corporate Presentation
|
|
DjohnR
|
118 |
25K |
6 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
118
|
25K
|
6
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Positive AD-214 Phase I extension study results
|
|
DjohnR
|
262 |
54K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
262
|
54K
|
3
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Positive AD-214 Phase I extension study results
|
|
DjohnR
|
262 |
54K |
2 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
262
|
54K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Countdown on to Adalta Trial Results
|
|
DjohnR
|
85 |
16K |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
85
|
16K
|
0
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Australia Biologics Festival Presentation
|
|
DjohnR
|
5 |
1.5K |
1 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
5
|
1.5K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
DjohnR
|
118 |
43K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
118
|
43K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
DjohnR
|
118 |
43K |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
118
|
43K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Q2 predictions?
|
|
DjohnR
|
55 |
18K |
5 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
55
|
18K
|
5
|
|
ASX - By Stock
|
1AD |
Countdown on to Adalta Trial Results
|
|
DjohnR
|
85 |
16K |
1 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
85
|
16K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD secures Share Facility Agreement of up to A$12.5m
|
|
DjohnR
|
23 |
8.6K |
3 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
23
|
8.6K
|
3
|
|
ASX - By Stock
|
AGH |
Re:
Vote No to Additional Placement
|
|
DjohnR
|
8 |
1.6K |
0 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
8
|
1.6K
|
0
|
|
ASX - By Stock
|
AGH |
Re:
Vote No to Additional Placement
|
|
DjohnR
|
8 |
1.6K |
0 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
8
|
1.6K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
DjohnR
|
701 |
281K |
3 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
701
|
281K
|
3
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
DjohnR
|
17 |
4.9K |
2 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
17
|
4.9K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
DjohnR
|
701 |
281K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
701
|
281K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Largest US Private Payor Updates Medical Policy for BIS
|
|
DjohnR
|
41 |
13K |
7 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
41
|
13K
|
7
|
|
ASX - By Stock
|
TYP |
Re:
PSYCHEDELICS Tryp Therapeutics and Exopharm Limited Sign Definitive Agreement
|
|
DjohnR
|
14 |
12K |
3 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
14
|
12K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: AGM Chairman's Address and Investor Presentation
|
|
DjohnR
|
75 |
22K |
3 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
75
|
22K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 Spotlight Presentation
|
|
DjohnR
|
20 |
10K |
6 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
20
|
10K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: AGM Chairman's Address and Investor Presentation
|
|
DjohnR
|
75 |
22K |
4 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
75
|
22K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
trading is changing .....
|
|
DjohnR
|
28 |
7.2K |
3 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
28
|
7.2K
|
3
|
|